Seres Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29, 2023; Webcast at 3:30 p.m. ET
28 Novembre 2023 - 3:18PM
Business Wire
Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome
therapeutics company, today announced that Seres management will
participate at the Piper Sandler 35th Annual Healthcare Conference
on Wednesday, November 29, 2023, at 3:30 p.m. ET.
An audio webcast of the presentation will be available under the
“Investors and News” section of Seres’ website. A replay of the
presentation will become available approximately one hour after the
event and will be archived for approximately 30 days.
About Seres Therapeutics
Seres Therapeutics, Inc. (Nasdaq: MCRB) is a commercial-stage
company developing novel microbiome therapeutics for serious
diseases. Seres’ lead program, VOWST™, obtained U.S. FDA approval
in April 2023 as the first orally administered microbiome
therapeutic to prevent recurrence of C. difficile infection (CDI)
in adults following antibacterial treatment for recurrent CDI and
is being commercialized in collaboration with Nestlé Health
Science. Seres is evaluating SER-155 in a Phase 1b study in
patients receiving allogeneic hematopoietic stem cell
transplantation. For more information, please visit
www.serestherapeutics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231127059541/en/
Investor and Media: Kevin Mannix
kmannix@serestherapeutics.com
Seres Therapeutics (NASDAQ:MCRB)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Seres Therapeutics (NASDAQ:MCRB)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024